
Cello Therapeutics
Nanoparticle developer specializing in cancer treatment solutions.
- 8
- Series A
Founded with a mission to revolutionize cancer treatment, Cello Therapeutics specializes in the development of advanced nanoparticle-based therapies. The company focuses on creating innovative nanomedicines designed to enhance the efficacy and reduce the side effects of chemotherapy and immunotherapy. By leveraging cutting-edge technology, Cello aims to provide more effective and targeted cancer treatments, addressing a critical need in the oncology market.
Cello Therapeutics has garnered attention from notable investors and industry experts due to its groundbreaking approach. The company has achieved significant milestones, including securing patents for its proprietary nanoparticle technologies and publishing influential research in leading scientific journals. Cello's impact is marked by its potential to significantly improve cancer treatment outcomes, offering hope to millions of patients worldwide.
Similar Companies

Cellics Therapeutics
cellics.com

Nanocan Therapeutics

PNP Therapeutics

Telo Therapeutics
SynerGene Therapeutics

Nanospectra Biosciences
nanospectra.com

NanoPharmaceuticals

Elucida Oncology

Palm Therapeutics

Cellerant Therapeutics

NanoMedTrix

NanoValent Pharmaceuticals

Duo Oncology
duooncology.com

Flashpoint Therapeutics
flashpoint.bio

Cour Pharmaceuticals Development
courpharma.com
Quick Facts
Who are Cello Therapeutics' competitors?
Companies similar to Cello Therapeutics include Cellics Therapeutics, Nanocan Therapeutics, PNP Therapeutics and Telo Therapeutics.
When was Cello Therapeutics founded?
Cello Therapeutics was founded in 2016.
Where is Cello Therapeutics' headquarters located?
Cello Therapeutics' headquarters is located in San Diego, CA, US.
When was Cello Therapeutics' last funding round?
Cello Therapeutics' most recent funding round was for $7.1M (USD) in August 2022.
How much disclosed funding has Cello Therapeutics raised?
As of Aug 22, 2022, Cello Therapeutics has disclosed funding of $8.7M (USD). Undisclosed round amounts are excluded.
How many employees does Cello Therapeutics have?
Cello Therapeutics has 8 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified